Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 18, 2003. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The only material change reported is a transaction involving the GlaxoSmithKline Employee Trust ("the GSK Trust"). On June 16, 2003, the trust transferred 45,262 Ordinary Shares to a participant in the SmithKline Beecham Employee Share Option Plan 1991.
Management Commentary and Risks
The filing notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Consequently, directors Dr. J-P Garnier and Mr. J D Coombe are interested in the shares held in the trust in the same manner as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares held by the GSK Trust following the transfer of 45,262 shares.
- Confirm the specific identity of the employee participant who received the shares under the 1991 Option Plan.
- Review the full 20-F annual report for comprehensive financial metrics not included in this 6-K filing.